ProQR Therapeutics


ProQR Therapeutics develops RNA therapies to potentially transform the lives of patients suffering from inherited retinal diseases.

Industries

Employees

51-200

Links


Org chart

Collapse
Gerard Platenburg
Chief Scientific Officer & Co-Founder
Andrew Morris
VP, Business Development
Sheila Sponselee
VP & Head, People & Operations
Sarah Kiely
VP, Investor Relations & Corporate Communications
Rene Beukema
Chief Corporate Development Officer & General Counsel
Vincent Adiceam
Vice President - Chief Of Staff To The CEO

Board & advisors

Dinko Valerio
Chairman, Supervisory Board
Alison Lawton
Board Of Directors
Bart Filius
Board Member
James Shannon
Board Member
Yi-Tao Yu
Scientific Advisor
Peter Beal
Scientific Advisor
Martin Maier
Scientific Advisor
John Maraganore
Strategic Advisor
Begoña Carreño
Scientific Advisor
Theresa Heggie
Scientific Advisor